Trius Therapeutics

Antifungals and immunotherapy: Cidara Therapeutics raises $42M Series B

San Diego biotech Cidara Therapeutics just raised an impressive $42 million Series B round –  with plans to speed up development of its antifungal and immunotherapy drugs, and bring them to clinical trial later this year. The startup has two antifungal programs underway – called Biafungin and Topifungin. Biafungin is meant to be a once-weekly intravenous […]

Pharma

Trius Therapeutics: Another lackluster biotech IPO (Morning Read)

Highlights of the important and the interesting from the world of healthcare: Another lackluster biotech IPO: Although shares of Trius Therapeutics closed flat on the anti-infective drug developer’s first day of trading, no matter what happened the company’s public debut has to be considered a disappointment. After hoping for a price of $12 to $14 […]

presented by
News

What could Foursquare mean for healthcare? (Morning Read)

Highlights of the important and the interesting from the world of healthcare: What could Foursquare mean for healthcare? Location-tracking services like Foursquare could make a big impact on our health and well-being in the future, reports ReadWriteWeb. Examples of the technology’s potential beneficial uses include tracking a doctor rushing to the hospital to care for […]